Growth Expected for Pharmaceutical Stocks amid Major Technology Exports... Annual 5 Percent Stock Fund Utilization Strategy
Recently, interest in the pharmaceutical and biotech industries has been rising as domestic pharmaceutical companies continue to license out new drug technologies—including obesity treatment drug candidates—to global corporations in quick succession. There is growing anticipation that one-time up-front payments, which are not subject to repayment obligations, could have a simultaneous impact on both revenue growth and profitability when they are reflected in company performance. With existing pharmaceutical businesses maintaining steady growth and the possibility of in-house developed obesity treatments being launched, attention is also focused on the foundation for growth after the milestone payments.
Investors are viewing this latest agreement not merely as a one-off positive event for individual companies, but as evidence that the drug development capabilities of domestic pharmaceutical firms are gaining international recognition. Although there is potential for increased interest in companies with additional technology export prospects and those showing clinical trial results, it is important to verify both the actual inflow of up-front payments and the achievement of milestones, rather than focusing solely on the scale of the agreement. For companies that have both licensing achievements and growth potential for proprietary products, it may be strategic to utilize periods of short-term correction as investment opportunities.
If additional funds are needed to seize investment opportunities, investors can utilize HiStockLoan’s stock investment products. Through a product with an annual interest rate of 5 percent, investors can manage investment funds up to four times their own capital, and the service can also be used to refinance existing margin loans or credit transactions. HiStockLoan leverages 22 years of accumulated expertise to offer a variety of options tailored to each investor’s financial situation and investment objectives.
[Industry No.1 HiStockLoan Direct Link: https://www.hisl.co.kr]
◆ HiStockLoan: Secure additional investment funds and refinance credit transactions with the industry’s lowest annual rate in the 5 percent range!
'HiStockLoan' has launched a securities-linked credit product with the industry’s lowest interest rate in the 5 percent range, making stock loans accessible to all investors without burden. Not only stock purchases, but also real-time refinancing of margin/credit transactions at securities companies are available, and anyone can utilize up to four times their own capital regardless of credit rating. In addition, investors using alternative exchanges (NXT) can also benefit from the service.
Investors interested in HiStockLoan’s diverse, customized products can contact the customer consultation center (☎1566-5113) for comprehensive assistance at any time, 24 hours a day, with expert advice available regardless of loan status.
○ Industry’s lowest annual rate product in the 5 percent range launched
○ ETF trading available
○ No.1 market share for 22 consecutive years, Korea First Brand Award winner for 17 consecutive years
○ Real-time repayment of margin/credit transactions at securities firms
○ Alternative exchange (NXT) trading available
○ Trusted consultation quality guarantee
* HiStockLoan Consultation Center: 1566-5113
Direct link: https://www.hisl.co.kr
Hyundai Motor, SK Square, LS ELECTRIC, Samsung Heavy Industries, Samsung Life Insurance
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
※ The above content is unrelated to the editorial direction of The Asia Business Daily, and all responsibility lies with the information provider.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.